| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants.
|
Science
|
2002
|
12.75
|
|
2
|
Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation.
|
Blood
|
2011
|
4.57
|
|
3
|
Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors.
|
Blood
|
2003
|
3.88
|
|
4
|
Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse.
|
J Clin Oncol
|
2005
|
3.81
|
|
5
|
Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value.
|
Blood
|
2007
|
3.32
|
|
6
|
Genetic PTX3 deficiency and aspergillosis in stem-cell transplantation.
|
N Engl J Med
|
2014
|
3.08
|
|
7
|
The effect of KIR ligand incompatibility on the outcome of unrelated donor transplantation: a report from the center for international blood and marrow transplant research, the European blood and marrow transplant registry, and the Dutch registry.
|
Biol Blood Marrow Transplant
|
2006
|
2.93
|
|
8
|
Preclinical characterization of 1-7F9, a novel human anti-KIR receptor therapeutic antibody that augments natural killer-mediated killing of tumor cells.
|
Blood
|
2009
|
2.75
|
|
9
|
Effect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated-donor haemopoietic-cell transplantation: a retrospective study.
|
Lancet Oncol
|
2012
|
2.68
|
|
10
|
Survival after T cell-depleted haploidentical stem cell transplantation is improved using the mother as donor.
|
Blood
|
2008
|
2.34
|
|
11
|
Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effect.
|
Blood
|
2002
|
2.20
|
|
12
|
NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo.
|
J Clin Invest
|
2009
|
2.08
|
|
13
|
Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants. Killer immunoglobulin-like receptor.
|
Blood
|
2002
|
2.03
|
|
14
|
Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients.
|
Blood
|
2011
|
1.74
|
|
15
|
Toward the identification of a tolerogenic signature in IDO-competent dendritic cells.
|
Blood
|
2005
|
1.56
|
|
16
|
Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation.
|
Blood
|
2005
|
1.54
|
|
17
|
Dectin-1 Y238X polymorphism associates with susceptibility to invasive aspergillosis in hematopoietic transplantation through impairment of both recipient- and donor-dependent mechanisms of antifungal immunity.
|
Blood
|
2010
|
1.52
|
|
18
|
A dendritic cell vaccine against invasive aspergillosis in allogeneic hematopoietic transplantation.
|
Blood
|
2003
|
1.45
|
|
19
|
Increased ratio of CD31+/CD42- microparticles to endothelial progenitors as a novel marker of atherosclerosis in hypercholesterolemia.
|
Arterioscler Thromb Vasc Biol
|
2006
|
1.36
|
|
20
|
Allogeneic hematopoietic transplantation and natural killer cell recognition of missing self.
|
Immunol Rev
|
2006
|
1.34
|
|
21
|
Exploitation of alloreactive NK cells in adoptive immunotherapy of cancer.
|
Curr Opin Immunol
|
2005
|
1.33
|
|
22
|
Natural killer cell alloreactivity in allogeneic hematopoietic transplantation.
|
Curr Opin Oncol
|
2007
|
1.27
|
|
23
|
Human leukocyte antigens A23, A24, and A32 but not A25 are ligands for KIR3DL1.
|
Blood
|
2008
|
1.20
|
|
24
|
Thymosin alpha1 activates dendritic cell tryptophan catabolism and establishes a regulatory environment for balance of inflammation and tolerance.
|
Blood
|
2006
|
1.18
|
|
25
|
NK cell alloreactivity and allogeneic hematopoietic stem cell transplantation.
|
Blood Cells Mol Dis
|
2007
|
1.11
|
|
26
|
TLR3 essentially promotes protective class I-restricted memory CD8⁺ T-cell responses to Aspergillus fumigatus in hematopoietic transplanted patients.
|
Blood
|
2011
|
1.09
|
|
27
|
Photodynamic purging of alloreactive T cells for adoptive immunotherapy after haploidentical stem cell transplantation.
|
Blood Cells Mol Dis
|
2007
|
1.06
|
|
28
|
Thymosin alpha 1 activates dendritic cells for antifungal Th1 resistance through toll-like receptor signaling.
|
Blood
|
2004
|
1.06
|
|
29
|
"Designed" grafts for HLA-haploidentical stem cell transplantation.
|
Blood
|
2013
|
1.03
|
|
30
|
Homozygosity for human leucocyte antigen-C ligands of KIR2DL1 is associated with increased risk of relapse after human leucocyte antigen-C-matched unrelated donor haematopoietic stem cell transplantation.
|
Br J Haematol
|
2005
|
1.01
|
|
31
|
Significance of ethnicity in the risk of acute graft-versus-host disease and leukemia relapse after unrelated donor hematopoietic stem cell transplantation.
|
Biol Blood Marrow Transplant
|
2013
|
1.00
|
|
32
|
Microparticles derived from endothelial progenitor cells in patients at different cardiovascular risk.
|
Atherosclerosis
|
2007
|
0.97
|
|
33
|
Immunoselection and clinical use of T regulatory cells in HLA-haploidentical stem cell transplantation.
|
Best Pract Res Clin Haematol
|
2011
|
0.97
|
|
34
|
Alloreactive natural killer cells in mismatched hematopoietic stem cell transplantation.
|
Blood Cells Mol Dis
|
2004
|
0.94
|
|
35
|
Protection of killer antiidiotypic antibodies against early invasive aspergillosis in a murine model of allogeneic T-cell-depleted bone marrow transplantation.
|
Infect Immun
|
2002
|
0.94
|
|
36
|
Dendritic cells pulsed with fungal RNA induce protective immunity to Candida albicans in hematopoietic transplantation.
|
J Immunol
|
2002
|
0.93
|
|
37
|
Natural killer cell alloreactivity for leukemia therapy.
|
J Immunother
|
2005
|
0.92
|
|
38
|
Haploidentical hematopoietic stem cell transplantation with a megadose T-cell-depleted graft: harnessing natural and adaptive immunity.
|
Semin Oncol
|
2012
|
0.91
|
|
39
|
Genetically-determined hyperfunction of the S100B/RAGE axis is a risk factor for aspergillosis in stem cell transplant recipients.
|
PLoS One
|
2011
|
0.91
|
|
40
|
Natural killer cell recognition of missing self and haploidentical hematopoietic transplantation.
|
Semin Cancer Biol
|
2006
|
0.91
|
|
41
|
The impact of donor natural killer cell alloreactivity on allogeneic hematopoietic transplantation.
|
Transpl Immunol
|
2005
|
0.87
|
|
42
|
Prospects for dendritic cell vaccination against fungal infections in hematopoietic transplantation.
|
Blood Cells Mol Dis
|
2004
|
0.85
|
|
43
|
Transplants across human leukocyte antigen barriers.
|
Semin Hematol
|
2002
|
0.85
|
|
44
|
Immunotherapeutic approaches for hematologic malignancies.
|
Hematology Am Soc Hematol Educ Program
|
2004
|
0.83
|
|
45
|
Natural killer cell alloreactivity in haploidentical hematopoietic stem cell transplantation.
|
Int J Hematol
|
2005
|
0.82
|
|
46
|
The cross-talk between opportunistic fungi and the mammalian host via microbiota's metabolism.
|
Semin Immunopathol
|
2014
|
0.81
|
|
47
|
Fourth International Workshop on Haploidentical Transplants, Naples, Italy, July 8-10, 2004.
|
Blood Cells Mol Dis
|
2004
|
0.80
|
|
48
|
CD40 ligation prevents onset of tolerogenic properties in human dendritic cells treated with CTLA-4-Ig.
|
Microbes Infect
|
2005
|
0.78
|
|
49
|
Hematopoietic stem cell transplantation from alternative donors for high-risk acute leukemia: the haploidentical option.
|
Curr Stem Cell Res Ther
|
2007
|
0.78
|
|
50
|
Expansion of CD56-negative, CD16-positive, KIR-expressing natural killer cells after T cell-depleted haploidentical hematopoietic stem cell transplantation.
|
Acta Haematol
|
2011
|
0.77
|
|
51
|
Jack of all trades: thymosin α1 and its pleiotropy.
|
Ann N Y Acad Sci
|
2012
|
0.77
|
|
52
|
Progress in understanding and exploiting the immune response in solid organ and hemopoietic stem cell transplantation.
|
Curr Opin Immunol
|
2009
|
0.76
|
|
53
|
Provision of antifungal immunity and concomitant alloantigen tolerization by conditioned dendritic cells in experimental hematopoietic transplantation.
|
Blood Cells Mol Dis
|
2007
|
0.76
|
|
54
|
Thymosin alpha1 to harness immunity to pathogens after haploidentical hematopoietic transplantation.
|
Ann N Y Acad Sci
|
2010
|
0.75
|
|
55
|
Natural killer cells as a therapeutic tool in mismatched transplantation.
|
Best Pract Res Clin Haematol
|
2004
|
0.75
|